Neurodevelopmental and neurofunctional outcomes in children with congenital diaphragmatic hernia

Enrico Danzer1, Holly L Hedrick

  • 1The Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, PA 1910, USA. danzere@email.chop.edu

Insights

Congenital diaphragmatic hernia (CDH) survivors often experience neurodevelopmental issues, including motor, behavioral, and cognitive challenges. Early identification and interdisciplinary care are crucial for managing these long-term outcomes.

Area of Science:

  • Pediatric Surgery
  • Developmental Neuroscience
  • Neonatology

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect with significant implications for infant survival and long-term health.
  • Advances in medical and surgical care have improved survival rates for CDH, shifting focus towards neurodevelopmental outcomes.
  • Neurodevelopmental dysfunction is a common and potentially disabling consequence of CDH and its treatment.

Purpose of the Study:

  • To critically review current knowledge on neurocognitive, neuromotor, and neurobehavioral development in patients with CDH.
  • To examine comprehensive outcome studies, identify predictors of adverse outcomes, and explore pathophysiological mechanisms.
  • To inform targeted interventions and establish standard care protocols for CDH patients.

Main Methods:

  • Literature review of comprehensive outcome studies in congenital diaphragmatic hernia.
  • Analysis of patient and disease-specific predictors for neurodevelopmental outcomes.
  • Examination of imaging studies and pathophysiological pathways related to brain abnormalities.

Main Results:

  • Neurodevelopmental dysfunction is the most common outcome in CDH patients, manifesting as neuromotor issues in infancy and behavioral/cognitive problems later.
  • Intelligence generally falls within the low normal range.
  • Structural brain abnormalities are frequently observed on imaging, and specific predictors of adverse outcomes have been identified.

Conclusions:

  • Understanding the pathophysiological basis of neurodevelopmental disabilities in CDH is key to developing targeted therapies.
  • Continuous, interdisciplinary assessment and follow-up are essential for early identification and management of morbidities.
  • Establishing standard care protocols can reduce adverse neurodevelopmental outcomes and improve the quality of life for children with CDH.